Evidence map›Paper›PMID 28685358›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2017

Asymmetric triacetate membrane keeps high water flux during ultrafiltration: in vitro study.

Yoshihiro Tange, Shingo Takesawa, Shigenori Yoshitake

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Nitric oxide delivery using nitric oxide-containing fluid in continuous hemofiltration: an in vitro study.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yoshihiro TangeDepartment of Medical Engineering, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan. tan@phoenix.ac.jp.ORCID http://orcid.org/0000-0003-2945-6194
Shingo TakesawaDepartment of Medical Engineering, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan.
Shigenori YoshitakeDepartment of Medical Engineering, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan.
Kyushu University of Health and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membrane fouling is a primary challenge encountered during the administration of hemodialysis (HD) and hemodiafiltration (HDF). A high-flux membrane is suitable for dialyzer reuse, since it is used repeatedly. Water flux is a benchmark used to assess the effectiveness of the dialysis membrane during treatment and it is usually evaluated to determine whether membrane fouling has occurred. Polysulfone (PS) membrane has good biocompatibility and solute permeability; however, polyethersulfone (PES) is often used as a hemodiafilter membrane because of better hydrophilicity compared to PS. We evaluated water flux across hemodiafilters using newly developed asymmetric triacetate (ATA) and PES as conventional membranes in vitro. Water flux of across ATA and PES membranes significantly decreased 30 min after the start of the experiments and thereafter showed stabilization. Water flux across the ATA membrane consistently showed significantly higher values of greater than 100 mL/m

Indexed as

Membranes, ArtificialAnimalsCattleCelluloseHemodiafiltrationPermeabilityPolymersSulfonesUltrafiltrationWaterCellulosecellulose triacetateMembranes, Artificialpolyether sulfonePolymerspolysulfone P 1700SulfonesWaterAsymmetric triacetate membranePolyethersulfone membraneWater flux

Identifiers

PMID28685358
OpenAlexW2727886923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.